Pamoja Capital

Mindgram is a science-based platform and mobile application focused on enhancing mental wellness. It aims to improve productivity by addressing stress and burnout through a range of services. The platform provides daily personalized coaching, psychological support for employees, and group workshops that can be conducted via chat or video calls. Mindgram enables employees to cultivate essential skills and effectively manage workplace challenges, fostering a healthier work environment.

The Nue Co. was born after a trip to Copenhagen inspired them to create a supplement brand founded on two danish principles, simplicity and creativity. Their lab has over 20 years experience and is based in Cambridge, England. Rather than working with harsh, isolated vitamins they choose to work with powerful organic foods high in specific vitamins or minerals. Every ingredient they use is completely traceable and of the highest standard. They never add fillers of any type, making their blends potent and pure.They limit the use of plastic packaging and are focused on minimising their carbon footprint.

Mindgram is a science-based platform and mobile application focused on enhancing mental wellness. It aims to improve productivity by addressing stress and burnout through a range of services. The platform provides daily personalized coaching, psychological support for employees, and group workshops that can be conducted via chat or video calls. Mindgram enables employees to cultivate essential skills and effectively manage workplace challenges, fostering a healthier work environment.

Talaris Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies aimed at eliminating chronic immunosuppression in organ transplant recipients. Its lead product, FCR001, is designed to enable living donor kidney transplant recipients to discontinue all long-term immunosuppression therapy within twelve months of their transplant. Additionally, the company's technology facilitates the safe administration of hematopoietic stem cells from unmatched and unrelated donors for bone marrow transplants, minimizing the risks associated with traditional methods. Founded in 1988 and based in Louisville, Kentucky, with an office in Wellesley, Massachusetts, Talaris Therapeutics has transitioned from its former name, Regenerex, Inc., in March 2019. The company is currently in the late stages of clinical development, also exploring applications for patients with severe autoimmune and immune-mediated disorders.

Vapogenix, Inc. is a clinical-stage company based in Houston, Texas, focused on developing non-narcotic analgesics aimed at treating localized pain. Founded in 2006, the company specializes in formulating volatile anesthetics to alleviate discomfort associated with procedures such as venipuncture, venous cannulation, and minor dermatological interventions. Vapogenix's products are designed to provide effective pain relief at the source, particularly for hospitalized children undergoing venous access procedures. By utilizing these innovative analgesics, Vapogenix aims to enhance patient comfort, reduce procedural anxiety, and improve the efficiency of healthcare providers.

Vapogenix, Inc. is a clinical-stage company based in Houston, Texas, focused on developing non-narcotic analgesics aimed at treating localized pain. Founded in 2006, the company specializes in formulating volatile anesthetics to alleviate discomfort associated with procedures such as venipuncture, venous cannulation, and minor dermatological interventions. Vapogenix's products are designed to provide effective pain relief at the source, particularly for hospitalized children undergoing venous access procedures. By utilizing these innovative analgesics, Vapogenix aims to enhance patient comfort, reduce procedural anxiety, and improve the efficiency of healthcare providers.